Variable | C15 | C160 | C15 & C160 | |||
---|---|---|---|---|---|---|
N=3,456 | N=1,568 | N=5,024 | ||||
n | % | n | % | n | % | |
Age at diagnosis group (years) | Â | Â | Â | Â | Â | Â |
<60 | 657 | 19.0 | 402 | 25.6 | 1,059 | 21.1 |
60–69 | 840 | 24.3 | 399 | 25.4 | 1,239 | 24.7 |
70–79 | 1,048 | 30.3 | 486 | 31.0 | 1,534 | 30.5 |
80+ | 911 | 26.4 | 281 | 17.9 | 1,192 | 23.7 |
Gender | Â | Â | Â | Â | Â | Â |
Female | 1,159 | 33.5 | 362 | 23.1 | 1,521 | 30.3 |
Male | 2,297 | 66.5 | 1,206 | 76.9 | 3,503 | 69.7 |
Country of Birth | Â | Â | Â | Â | Â | Â |
Australia | 2,497 | 72.2 | 1,063 | 67.8 | 3,560 | 70.9 |
Other | 959 | 37.8 | 505 | 32.2 | 1,464 | 29.1 |
Histology group | Â | Â | Â | Â | Â | Â |
SCC | 1,478 | 42.8 | 70 | 4.5 | 1,548 | 30.8 |
Adenocarcinomas | 1,549 | 44.8 | 1,398 | 89.2 | 2,947 | 58.7 |
Other | 293 | 8.5 | 79 | 5.0 | 372 | 7.4 |
Degree of Spread | Â | Â | Â | Â | Â | Â |
Localised | 1,290 | 37.3 | 435 | 27.7 | 1,725 | 34.3 |
Regional | 692 | 20.0 | 543 | 34.6 | 1,235 | 24.6 |
Distant | 622 | 18.0 | 387 | 24.7 | 1,009 | 20.1 |
Unknown | 721 | 20.9 | 203 | 12.9 | 924 | 18.4 |
Tumour location | Â | Â | Â | Â | Â | Â |
Upper | 297 | 8.6 | Â | Â | 297 | 5.9 |
Middle | 470 | 13.8 | Â | Â | 470 | 9.4 |
Lower | 1,528 | 45.0 | Â | Â | 1,528 | 30.9 |
NOS* | 1,113 | 32.7 | Â | Â | 1,113 | 22.2 |
GOJ* | Â | Â | 1,568 | Â | 1,568 | 31.2 |
Charlson comorbidity | Â | Â | Â | Â | Â | Â |
0 | 3,098 | 89.6 | 1,431 | 91.2 | 4,529 | 90.1 |
1,2 | 331 | 9.6 | 124 | 7.9 | 455 | 9.1 |
3+ | 27 | 0.8 | 13 | 0.8 | 40 | 0.8 |